BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

445 related articles for article (PubMed ID: 10468968)

  • 21. Thyroid response, especially to thyrotropin-binding inhibitory immunoglobulins, in euthyroid relatives of patients with Graves' disease: a clinical follow-up.
    Tamai H; Kasagi K; Morita T; Hidaka A; Kuma K; Konishi J; Kumagai LF; Nagataki S
    J Clin Endocrinol Metab; 1990 Jul; 71(1):210-5. PubMed ID: 1973421
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Follow-up study of thyroid stimulating-blocking antibodies in hypothyroid patients.
    Tamai H; Kasagi K; Hara T; Hidaka A; Morita T; Kuma K; Konishi J; Kumagai LF; Nagataki S
    Clin Endocrinol (Oxf); 1990 Dec; 33(6):699-707. PubMed ID: 1982862
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Subacute thyroiditis with thyroid-stimulation blocking antibodies: a case report.
    Nakamura S; Saio Y; Suzuki E
    Endocr J; 1996 Apr; 43(2):185-9. PubMed ID: 8793334
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transient congenital hypothyroidism due to maternal thyrotrophin binding inhibiting immunoglobulin.
    Schwingshandl J; Donaghue K; Luttrell B; Cowell C; Ward P; Silink M
    J Paediatr Child Health; 1993 Aug; 29(4):315-8. PubMed ID: 8104016
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Thyrotropin binding inhibiting immunoglobulins (TBII) in Graves' disease, toxic nodular goitre and autoimmune thyroiditis.
    Wägar G; Mäkinen T; Lamberg BA; Gordin A; Apter L; Pekonen F
    Ann Clin Res; 1982 Apr; 14(2):83-9. PubMed ID: 6184007
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Disappearance of thyroid-stimulation blocking antibody by glucocorticoid therapy in a patient with primary myxedema who developed aortitis syndrome during L-thyroxine supplementation.
    Shigemasa C; Kouchi T; Taniguchi S; Mitani Y; Mashiba H
    J Endocrinol Invest; 1990 May; 13(5):415-8. PubMed ID: 1974269
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical value of a new TSH binding inihibitory activity assay using human TSH receptors in the follow-up of antithyroid drug treated Graves' disease. Comparison with thyroid stimulating antibody bioassay.
    Maugendre D; Massart C
    Clin Endocrinol (Oxf); 2001 Jan; 54(1):89-96. PubMed ID: 11167931
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical significance of anti-TSH antibody in sera from patients with Graves' disease and other thyroid disorders.
    Akamizu T; Mori T; Imura H; Noh J; Hamada N; Ito K; Koizumi Y; Yamada T; Fujihira T; Eto S
    J Endocrinol Invest; 1989; 12(7):483-8. PubMed ID: 2571629
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Detection and properties of TSH-binding inhibitor immunoglobulins in patients with Graves' disease and Hashimoto's thyroiditis.
    Endo K; Kasagi K; Konishi J; Ikekubo K; Okuno T; Takeda Y; Mori T; Torizuka K
    J Clin Endocrinol Metab; 1978 May; 46(5):734-9. PubMed ID: 45421
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Compared with classic Hashimoto's thyroiditis, chronic autoimmune serum-negative thyroiditis requires a lower substitution dose of L-thyroxine to correct hypothyroidism.
    Croce L; De Martinis L; Pinto S; Coperchini F; Dito G; Bendotti G; Pasquali D; Cappelli C; Latrofa F; Magri F; Chiovato L; Rotondi M
    J Endocrinol Invest; 2020 Nov; 43(11):1631-1636. PubMed ID: 32319047
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Blocking type antithyrotropin receptor antibody in patients with nongoitrous hypothyroidism: its incidence and characteristics of action.
    Arikawa K; Ichikawa Y; Yoshida T; Shinozawa T; Homma M; Momotani N; Ito K
    J Clin Endocrinol Metab; 1985 May; 60(5):953-9. PubMed ID: 2858492
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of thyroid stimulating antibody (TSAb) in the thyroid function of patients with post-partum hypothyroidism.
    Hara T; Tamai H; Mukuta T; Fukata S; Kuma K
    Clin Endocrinol (Oxf); 1992 Jan; 36(1):69-74. PubMed ID: 1348451
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Thyroid-stimulating antibody and TSH-binding inhibitor immunoglobulin in 277 Graves' patients and in 686 normal subjects.
    Takasu N; Oshiro C; Akamine H; Komiya I; Nagata A; Sato Y; Yoshimura H; Ito K
    J Endocrinol Invest; 1997 Sep; 20(8):452-61. PubMed ID: 9364248
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Detection of low titre TBII in patients with Graves' disease using recombinant human TSH receptor.
    Morgenthaler NG; Nagata A; Katayama S; Bergmann A; Iitaka M
    Clin Endocrinol (Oxf); 2002 Aug; 57(2):193-8. PubMed ID: 12153597
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pathogenetic role of thyrotropin receptor antibody in the development of hyperthyroidism following primary hypothyroidism.
    Shong YK; Cho BY; Hong SK; Lee HK; Koh CS; Min HK
    Korean J Intern Med; 1989 Jul; 4(2):118-24. PubMed ID: 2577256
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Demonstration of anti-TSH antibody in TSH binding inhibitory immunoglobulin-positive sera of patients with Graves' disease.
    Ochi Y; Hamazu M; Kajita Y; Nagata A
    Clin Endocrinol (Oxf); 2002 Mar; 56(3):405-12. PubMed ID: 11940054
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Radioreceptor assay of anti-TSH receptor antibody activity: comparison of assays using unextracted serum and immunoglobulin fractions, and standardization of expression of activities.
    Tamaki H; Amino N; Watanabe Y; Aozasa M; Hayashi H; Tachi J; Miyai K
    J Clin Lab Immunol; 1986 May; 20(1):1-6. PubMed ID: 3016274
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of serum basal thyrotrophin levels and thyrotrophin receptor antibody activities as prognostic markers for discontinuation of antithyroid drug treatment in patients with Graves' disease.
    Cho BY; Shong MH; Yi KH; Lee HK; Koh CS; Min HK
    Clin Endocrinol (Oxf); 1992 Jun; 36(6):585-90. PubMed ID: 1358483
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Conversion to Graves disease from Hashimoto thyroiditis: a study of 24 patients.
    Gonzalez-Aguilera B; Betea D; Lutteri L; Cavalier E; Geenen V; Beckers A; Valdes-Socin H
    Arch Endocrinol Metab; 2018; 62(6):609-614. PubMed ID: 30624501
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of thyroid-stimulating blocking antibodies that appeared during transient hypothyroidism after radioactive iodine therapy.
    Kung AW; Lau KS; Kohn LD
    Thyroid; 2000 Oct; 10(10):909-17. PubMed ID: 11081257
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.